Current Headlines
-
BioCentriq Selected To Present Its Capabilities At Meeting On The Mesa
8/2/2023
Organized by the Alliance for Regenerative Medicine, the Cell & Gene Meeting on the Mesa is a three-day conference that addresses the commercialization challenges of today’s cell and gene therapy industry.
-
Federal Equipment Company Announces Biopharma Equipment Asset Auction For August 8-9
7/31/2023
Don’t miss our latest auction from Federal Equipment featuring assets from Akorn Pharmaceuticals. Bidding runs August 8-9, 2023.
- Fina Biosolutions Selects Scorpius BioManufacturing For Production Of cGMP CRM197 7/27/2023
-
New Cell Therapy CDMO Kincell Bio To Develop In-House Manufacturing Capacity
7/26/2023
Kincell Bio, a technology-forward contract development and manufacturing organization (CDMO) focused on cell therapies, today emerged from stealth with $36 million in new funding. Kineticos Ventures led Kincell’s launch funding.
-
CDMO Biovian Announces Significant Investment Into Drug Manufacturing Facility In Finland
7/26/2023
Biovian Oy, a leading contract development and manufacturing organization (CDMO) specializing in biopharmaceuticals, announces a major investment of over €50 million to expand its manufacturing facility in Turku, Finland.
-
Qosina Introduces Aramus™ 2D Bag Chambers From Entegris To Its Bioprocess Components Portfolio
7/20/2023
Qosina is pleased to announce the addition of Aramus 2D bag chambers from Entegris.
-
Sandoz Announces Plans To Build New Technical Development Center In Slovenia
7/20/2023
Sandoz, a global leader in generic and biosimilar medicines, today announced an investment of approximately USD 90 million at its site in Ljubljana, Slovenia to establish a dedicated Sandoz Biopharma Development Center by 2026.
-
Entegris And Agilitech: Transforming Single-Use Technologies
7/19/2023
Entegris announces their collaboration with Agilitech, allowing them to offer an extended line of custom, single-use systems for cell and gene therapies.
-
metabion Expands Production Capacity For Diagnostic And Therapeutic Oligonucleotides In Munich East
7/13/2023
metabion has increased its global production capacity for diagnostic and newly introduced therapeutic oligonucleotides and derivatives thereof to support the rising demand in Europe and worldwide.
- Signant Health Extends The Power Of Clinical Supply Management Software To The Small & Mid-Size Market Through Updated & Enhanced Supplies Platform 7/10/2023